PharmaCyte Biotech
PMCB----
Q1 FY2027 Earnings
Financial report interval: 2026.05.01 - 2026.07.31
Overview: PharmaCyte Biotech(PMCB) the EBIT is -1.007 M (-18.67%);the EPS is -0.539 (+56.19%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B18.67%
----
----
EPS
-0.538956.19%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf